🇺🇸 Reduction in antimetabolite immunosuppression in United States

Reduction in antimetabolite immunosuppression (Reduction in antimetabolite immunosuppression) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Reduction in antimetabolite immunosuppression in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Reduction in antimetabolite immunosuppression approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Reduction in antimetabolite immunosuppression in United States?

University of California, Davis is the originator. The local marketing authorisation holder may differ — check the official source linked above.